
Alfa Cytology Launches PrimePDX™ Platform to Address Immuno-Oncology Research Gaps
Alfa Cytology's new PrimePDX™ platform enhances preclinical cancer modeling by incorporating human immune cells into tumor models, addressing limitations in traditional approaches for immunotherapy research.
Read full story























